HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

NCT07425054 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer
HPV-Related Carcinoma
Squamous Cell Carcinoma of the Anus

Interventions

RADIATION: HPV ctDNA Response based radiation
DRUG: Chemotherapy
DRUG: Retifanlimab

Sponsor

Jennifer Dorth

Collaborators

[object Object]